| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/16/2008 | CN100362019C Recombinant erythropoietin with intracorporeal physical activity and modified by macrogol |
| 01/16/2008 | CN100361706C Expanding diuretic for treating pulmonary edema in perioperative period of hepatic and biliary diseases |
| 01/16/2008 | CN100361681C Medicine for treating thrombocytopenia and anemia and its prepn process and quality control method |
| 01/16/2008 | CN100361672C Red sage root ligustrazine freeze dried injecta and preparation method thereof |
| 01/16/2008 | CN100361656C Butylbenzene phthalein self emulsifying releasing medicine system, preparation method and application |
| 01/15/2008 | US7319100 1-(1H-Pyrazin-2-on-3-yl)tetrahydroquinolines (3-(8-Bromo-6-methoxy-1,2,3,4-tetrahydroquinoline)-5-chloro-1-(1-ethylpropyl)-2(1H)-pyrazinone); treating anxiety and depression |
| 01/15/2008 | CA2134750C Truncated tissue factor and fviia or fvii activator for blood coagulation |
| 01/10/2008 | WO2008005348A1 Synthesis of diethyl{ i5' (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
| 01/10/2008 | WO2008005262A1 Substituted bicyclic and tricyclic thrombin receptor antagonists |
| 01/10/2008 | WO2008004946A1 New pyridine analogues |
| 01/10/2008 | WO2008004945A1 Novel crystalline forms i and ii |
| 01/10/2008 | WO2008004944A1 Novel crystalline form ii |
| 01/10/2008 | WO2008004943A1 New pyridine analogues |
| 01/10/2008 | WO2008004942A1 New pyridine analogues |
| 01/10/2008 | WO2008004941A1 New pyridine analogues |
| 01/10/2008 | WO2008004598A1 Erythropoietin-producing organoid precursor, method of constructing the same and method of treating erythropoietin-related disease |
| 01/10/2008 | WO2008003259A1 An extract for preventing or treating thrombotic diseases |
| 01/10/2008 | WO2007136689A3 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor |
| 01/10/2008 | WO2007136680A3 3-pyraz0lyl-benzamide-4-ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/10/2008 | WO2007131982A3 Substituted prolinamides, production thereof and their use as drugs |
| 01/10/2008 | WO2006135621A3 Method for renin-angiotensin-aldosterone system activation and control thereof |
| 01/10/2008 | WO2006089966A8 Fxiii variants with improved properties |
| 01/10/2008 | US20080009457 Reaction of Rna and cochleate |
| 01/10/2008 | US20080009453 Pharmceutical Compositions Containing Polydatin or Its Salts and Their Application |
| 01/10/2008 | US20080009446 Recombinant human albumin fusion proteins with long-lasting biological effects |
| 01/10/2008 | US20080009042 separating the yeast from the culture medium to yield an albumin solution; subjecting the albumin solution to positive mode cation exchange, affinity, and positive mode anion exchange chromatography; and concentrating and formulating the albumin with sodium octanoate and sodium chloride |
| 01/10/2008 | US20080008762 Steroid Formulation And Methods Of Treatment Using Same |
| 01/10/2008 | US20080008651 Screening Methods and Transgenic Animals for the Treatment of Beta-Globin Related Disease and Conditions |
| 01/10/2008 | CA2658060A1 Erythropoietin-producing organoid precursor, production method thereof, and method for treating erythropoietin-related disorder |
| 01/10/2008 | CA2656597A1 New pyridine analogues |
| 01/10/2008 | CA2656265A1 Synthesis of diethyl{ i5" (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
| 01/10/2008 | CA2655720A1 Substituted bicyclic and tricyclic thrombin receptor antagonists |
| 01/10/2008 | CA2655633A1 New pyridine analogues |
| 01/10/2008 | CA2655629A1 New pyridine analogues |
| 01/10/2008 | CA2655628A1 New pyridine analogues |
| 01/09/2008 | EP1876240A1 Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 01/09/2008 | EP1876236A1 Antibody substituting for function of blood coagulation factor viii |
| 01/09/2008 | EP1875924A2 RGD-enriched gelatine-like proteins with enhanced cell binding |
| 01/09/2008 | EP1875919A1 Artificial cerebrospinal fluid |
| 01/09/2008 | EP1874780A1 4-piperazinylthieno[2,3-d]pyrimidine compounds as platelet aggregation inhibitors |
| 01/09/2008 | EP1874764A2 Imino-oxazolidines and use thereof as anticoagulants |
| 01/09/2008 | EP1874349A2 Use of cd25 antibodies in immunotherapy |
| 01/09/2008 | EP1874341A1 Erythrocytes containing arginine deiminase |
| 01/09/2008 | EP1874306A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 01/09/2008 | EP1409449B1 Alpha-ketoglutarates of active ingredients and compositions containing same |
| 01/09/2008 | EP1263730B1 Amine derivatives for the treatment of apoptosis |
| 01/09/2008 | EP1115416B1 Use of substances with oxytocin activity in order to create cell regeneration |
| 01/09/2008 | EP1044009B1 Methods and compositions employing red rice fermentation products |
| 01/09/2008 | CN101103022A New carboxylic acid amide used as XA inhititor |
| 01/09/2008 | CN101103013A 1-thio-D-glucitol derivatives |
| 01/09/2008 | CN101102819A Prevention of thrombus formation and/or stabilization |
| 01/09/2008 | CN101102818A Medicaments comprising carbonyl compounds, and the use thereof |
| 01/09/2008 | CN101100688A Method for extracting and purifying dermatan sulfate in angler fish skin |
| 01/09/2008 | CN101099766A Medical new use of kadsura coccinea root |
| 01/09/2008 | CN101099734A Agonism of the 5ht2a receptor for treatment of thermoregulatory dysfunction |
| 01/09/2008 | CN100360628C Adhesive |
| 01/09/2008 | CN100360563C Recombinant VPAC2 receptor specific agonist RMBAY, its expression and use |
| 01/09/2008 | CN100360562C Recombinant VPAC2 receptor specific agonist RMROM, its expression and use |
| 01/09/2008 | CN100360554C Peptide conjugate |
| 01/09/2008 | CN100360519C Benzothiepine ileal bile acid transport inhibitors |
| 01/09/2008 | CN100360499C Propanoic acid derivatives that inhibit binding of integrins to their receptors |
| 01/09/2008 | CN100360159C Kidney benefiting, Chong collateral reinforcing and menstruation regulating hemostat |
| 01/08/2008 | US7317014 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 01/08/2008 | US7316911 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
| 01/08/2008 | US7316818 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
| 01/08/2008 | CA2408602C Phenylglycine derivatives |
| 01/06/2008 | CA2563116A1 Methods for treating or preventing anemia or thrombocytopenia using a triheterocyclic compound |
| 01/03/2008 | WO2008002247A1 New pyridine analogues |
| 01/03/2008 | WO2008001444A1 Phosphoric acid-adsorbing drug for external use having effect of inhibiting microbial growth, product containing the same and method of producing the same |
| 01/03/2008 | WO2008001443A1 Preventive remedial therapeutic agent for phosphorus impairment, oral agent for adsorbing phosphate ion contained in food, beverage and chemical, and process for producing them |
| 01/03/2008 | WO2008001442A1 Anion adsorbent, water or soil cleanup agent and process for producing the same |
| 01/03/2008 | US20080004298 3-hydroxypropylsulfamic acid {5-(4-bromophenyl)-6-[2-(5-bromoprimidin-2-yloxy)-ethoxy]-pyrimidin-4-yl}-amide, used for treatment of hypertension, congestive heart failure, renal and myocardial ischemia, renal failure, ischemia, dementia, headaches, hemorrhage, Raynaud's syndrome and ulcers |
| 01/03/2008 | US20080004293 Adenosine receptor antagonists and methods of making and using the same |
| 01/03/2008 | US20080004267 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | US20080004256 Amidinophenylalanine Derivatives as Thrombin Inhibitors |
| 01/03/2008 | US20080004225 New dialysis method |
| 01/03/2008 | US20080004221 High Molecular Weight Derivatives of Vitamin K-Dependent Polypeptides |
| 01/03/2008 | US20080004216 Modified vitamin K-dependent polypeptides |
| 01/03/2008 | US20080003214 Medicaments Comprising Carbonyl Compounds, And The Use Thereof |
| 01/03/2008 | US20080003212 ATP Diphosphohydrolase (CD39) Gene Therapy for Inflammatory or Thrombotic Conditions for Transplantation and Means Therefor |
| 01/03/2008 | CA2655228A1 New pyridine analogues |
| 01/02/2008 | EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/02/2008 | EP1873154A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF |
| 01/02/2008 | EP1873153A1 Heterocyclic compound |
| 01/02/2008 | EP1872797A2 Treatment of cardiovascular and related pathologies |
| 01/02/2008 | EP1871741A2 Substituted azetidinones |
| 01/02/2008 | EP1465643B1 Methods and compositions for oxygen transport with high oxygen affinity |
| 01/02/2008 | EP1432802B1 Pegylated and diglycosylated erythropoietin |
| 01/02/2008 | EP1381376B1 Water-absorbent polymers and their use |
| 01/02/2008 | EP1121116B1 Sustained release pharmaceutical composition of fluvastatin |
| 01/02/2008 | CN101098687A Method of modulating b cell functioning |
| 01/02/2008 | CN101098686A Glycogen synthase kinase-3 inhibitors |
| 01/02/2008 | CN101095956A Scutellarin prodrug using carboxymethyl chitosan as the carrier and method for preparing the same |
| 01/02/2008 | CN101095955A Scutellarin prodrug using poly-aspartate derivant as the carrier and method for preparing the same |
| 01/02/2008 | CN101095765A Chinese traditional medicine preparations for treating dysfunctional uterine bleeding |
| 01/02/2008 | CN101095751A Medicinal composition having functions of removing chloasma and improving nutritional anemia and method for preparing the same |
| 01/02/2008 | CN101095720A Method for preparing total salvianolic acid and the application in the preventing and treating of diabetes and the complication thereof |
| 01/02/2008 | CN101095697A Extractive of bdella and/or lumbricus with the molecular weight below 5800 dalton |
| 01/02/2008 | CN100358919C Mammal prolactin variants |
| 01/02/2008 | CN100358892C 7-oxo pyridopyrimidines |